MiCo BioMed Co. Ltd. engages in the development, manufacture and sale of in vitro diagnosis medical devices and diagnostic reagents. It operates through the Molecular diagnosis business division and Biochemical diagnosis business division. The Molecular diagnosis business division engages in the production of nuclear acid extraction and real-time polymerase chain reaction instrument, reagents and lab on a chip. The Biochemical diagnosis business division engages in the production of combine diagnostic equipment, anemia measuring instrument, blood glucose measuring equipment and others. The company was founded on March 6, 2009 and is headquartered in Seongnam-si, South Korea.